Study guide
18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
Arab Board Pediatrics Part 1 Written Examination ABHS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy
2 Neonatal Care I
2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia
3 Neonatal Care II
3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening
4 Infectious Diseases
4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections
5 Immunization
5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations
6 Allergy & Immunology
6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy
7 Growth & Development
7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders
8 Nutrition
8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)
9 Pediatric Emergencies I
9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology
10 Pediatric Emergencies II
10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding
11 Cardiology
11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease
12 Respiratory
12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders
13 Gastroenterology
13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia
14 Nephrology & Genitourinary
14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies
15 Hematology & Oncology
15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency
16 Endocrinology
16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty
17 Neurology
17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache
18 Genetics, Dysmorphology & Metabolism
18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
19 Fluids, Electrolytes & Pharmacology
19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing
20 Dermatology, ENT, Ophthalmology & Musculoskeletal
20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders
21 Adolescent Medicine & Ethics
21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics
22 Final Review & Exam Strategy
22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management
18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
Key Takeaways Explain This Topic AI
Autosomal recessive conditions require two mutant alleles; when both parents are unaffected carriers, each pregnancy carries a 25% chance of an affected child, 50% chance of a carrier child, and 25% chance of a fully unaffected child.
Parental consanguinity sharply raises the probability that both parents carry the same rare recessive allele inherited from a common ancestor, which is why autosomal recessive inborn errors of metabolism are disproportionately represented in this exam's patient population.
X-linked recessive conditions typically affect males, with carrier mothers passing the trait to 50% of sons (affected) and 50% of daughters (carriers); father-to-son transmission does not occur because fathers pass a Y chromosome to sons.
A well infant who develops poor feeding, vomiting, lethargy, or seizures after the introduction of feeds — with a normal initial newborn exam — should trigger an inborn-error-of-metabolism workup, especially checking serum ammonia, glucose, and blood gas early.
Elevated ammonia with respiratory alkalosis (not acidosis) points to a urea cycle defect, while metabolic acidosis with an elevated anion gap and ketosis points more toward an organic acidemia.
Last updated: July 2026
Why Inheritance and Metabolism Matter on This Exam
This exam tests Mendelian genetics through pedigree-style reasoning and regional clinical context rather than abstract definitions alone. Parental consanguinity — common across many Arab Board patient populations — sharply increases autosomal recessive disease risk and is a recurring clue in metabolic-disease vignettes. The single highest-yield metabolic pattern is the well newborn who deteriorates after feeds begin ; using ammonia, glucose, and acid-base status to triage among urea cycle defects, organic acidemias, and fatty acid oxidation disorders is what separates a passing from a failing answer.
Mendelian Inheritance Patterns
Understanding single-gene ( Mendelian ) inheritance patterns lets you predict recurrence risk from a family pedigree — a core skill tested through worked scenarios rather than definitions alone.
Autosomal Dominant (AD)
A single mutant allele on one of the 22 autosomes causes disease. Key pedigree features: the trait appears in every generation (vertical transmission), an affected parent has a 50% chance of passing the condition to each child regardless of the child's sex, and unaffected individuals do not transmit the trait (assuming full penetrance). Examples relevant to pediatrics include neurofibromatosis type 1, tuberous sclerosis, achondroplasia, and Marfan syndrome.
Worked example: A father with achondroplasia (heterozygous) and an unaffected mother have three children. Each pregnancy independently carries a 50% chance of an affected child — it is incorrect to assume that because one child is already affected, the next is more likely to be unaffected (each pregnancy is an independent Bernoulli trial).
Autosomal Recessive (AR)
Disease requires two mutant alleles , one from each parent. Typically both parents are unaffected carriers (heterozygotes). Key pedigree feature: the trait often appears to "skip generations" and clusters in siblings rather than appearing in parents. When both parents are carriers, each pregnancy has:
- Outcome Probability
- Affected (homozygous mutant) 25%
- Unaffected carrier (heterozygous) 50%
- Fully unaffected (homozygous normal) 25%
Most inborn errors of metabolism are autosomal recessive, which is why this pattern is the backbone of the metabolic-disease topic below.
X-Linked Recessive
The mutant gene sits on the X chromosome. Because males are hemizygous (only one X), a single mutant X-linked recessive allele is sufficient to cause disease in a male, while females typically need two mutant copies (or are carriers with mild/no expression, subject to X-inactivation effects). Classic pattern: a carrier mother (heterozygous, unaffected) has, per pregnancy, a 50% chance of an affected son , a 50% chance of a carrier daughter , and no father-to-son transmission (fathers give sons a Y chromosome, not an X). An affected father passes the mutant X to all daughters (obligate carriers) but to no sons . Examples: Duchenne muscular dystrophy, hemophilia A/B, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and X-linked forms of ornithine transcarbamylase (OTC) deficiency (see below).
Worked pedigree example: A mother is a known carrier for Duchenne muscular dystrophy (her brother is affected, confirming her carrier status). She and an unaffected husband plan a pregnancy. For each son, risk of being affected is 50%; for each daughter, risk of being a carrier is 50% and risk of being affected is negligible (would require the father to also carry/express the allele, which is not the case here).
Consanguinity and Autosomal Recessive Risk — Regionally Critical
Consanguinity (marriage between blood relatives, most commonly first cousins in this exam's patient populations) is common across many countries served by the Arab Board and substantially raises the probability that both parents inherited the same rare recessive allele from a shared ancestor — a phenomenon called identity by descent . For first-cousin unions, the coefficient of relationship is 1/8, meaning the couple shares, on average, one-eighth of their genes by descent; this raises the baseline risk of a rare autosomal recessive disorder in offspring several-fold above the general population baseline, and the relative risk increase is largest for very rare alleles (where the alternative — two unrelated carriers meeting by chance — is exceedingly unlikely).
Clinically, this means:
A history of parental consanguinity should raise your index of suspicion for an autosomal recessive inborn error of metabolism, a recessive skeletal dysplasia, or a recessive form of hearing loss/blindness whenever a child presents with an unexplained multisystem or progressive illness.
Recurrent unexplained neonatal deaths or a family history of early infant deaths in a consanguineous family is a strong exam clue pointing toward a recessive metabolic disease , not an isolated congenital anomaly.
Genetic counseling for consanguineous couples should include a detailed three-generation pedigree and, when a specific recessive disorder is suspected or has occurred in the family, carrier testing before or early in a subsequent pregnancy.
Approach to Inborn Errors of Metabolism (IEM) in the Newborn/Infant
Most IEMs are individually rare but collectively common, and nearly all are inherited in an autosomal recessive pattern (with important X-linked exceptions, notably OTC deficiency). The unifying exam pattern is the well newborn who deteriorates after a symptom-free interval — typically once feeds (breast milk or formula, both of which contain protein and/or lactose) begin.
When to Suspect a Metabolic Disease
Normal at birth, then poor feeding, vomiting, lethargy, hypotonia, or seizures after 24-72 hours (once feeding introduces the offending substrate)
Unexplained/recurrent encephalopathy without a clear infectious or hypoxic cause, especially with a normal septic workup
Unusual odor of urine or sweat (e.g., "maple syrup" odor in maple syrup urine disease, "musty" odor in phenylketonuria, "sweaty feet" odor in isovaleric acidemia)
A history of parental consanguinity or a prior unexplained sibling death/illness in infancy
Hepatomegaly , cataracts, or coarse facial features developing over time (more typical of storage disorders than acute intoxication-type IEMs, but still on the differential)
Newborn Screening and Phenylketonuria (PKU)
Phenylketonuria (PKU) and classic galactosemia are the two prototype amino-sugar disorders on newborn screening panels. PKU is caused by deficiency of phenylalanine hydroxylase , the enzyme that converts phenylalanine to tyrosine; deficiency causes phenylalanine to accumulate to neurotoxic levels. It is the prototype disorder detected by newborn screening (a heel-stick blood spot obtained after feeding has begun, generally in the first days of life). Untreated PKU causes progressive intellectual disability, seizures, eczema, a characteristic musty odor , and hypopigmentation (fair hair/skin, from reduced tyrosine-derived melanin) — but because treatment (a phenylalanine-restricted diet, begun as soon as screening flags an elevated level) is highly effective at preventing these outcomes, PKU is the classic exam example of why universal newborn screening exists : the disease is asymptomatic at birth, screening catches it before irreversible damage occurs, and early dietary treatment produces a normal or near-normal outcome.
Galactosemia results from deficiency of galactose-1-phosphate uridyltransferase (GALT), blocking metabolism of galactose from lactose in breast milk or standard formula. Affected infants develop jaundice, vomiting, hepatomegaly, and hypoglycemia after milk feeds begin, and are at risk for E. coli sepsis in the neonatal period. Urine shows reducing substances (not glucose-specific) while blood glucose may be low. Treatment is immediate removal of lactose/galactose from the diet (soy or lactose-free formula); breastfeeding is contraindicated.
Urea Cycle Defects and Hyperammonemia
The urea cycle converts nitrogen waste from protein metabolism into urea for excretion; a block anywhere in this pathway causes ammonia to accumulate. Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle defect and the important exception to "most IEMs are autosomal recessive" — it is X-linked , so affected males present severely in the newborn period while carrier females may be asymptomatic or have milder, later-onset disease.
Clinical picture: a full-term newborn feeds well for the first 24-48 hours, then develops poor feeding, vomiting, lethargy progressing to coma, and seizures — closely mimicking neonatal sepsis, which is why sepsis and a urea cycle defect are frequently paired as a "do not miss the other diagnosis" exam scenario. The critical laboratory clue is markedly elevated serum ammonia in the setting of respiratory alkalosis (hyperammonemia directly stimulates the respiratory center, causing hyperventilation and a high pH with low carbon dioxide) — this is a key discriminator from an organic acidemia, which instead produces a metabolic acidosis with an elevated anion gap , often with ketosis.
Rapid Triage Table
Clue Points toward
High ammonia + respiratory alkalosis, normal glucose, no significant acidosis Urea cycle defect (e.g., OTC deficiency)
High anion gap metabolic acidosis + ketosis +/- mild hyperammonemia Organic acidemia (e.g., propionic or methylmalonic acidemia)
Hypoglycemia without significant ketosis ("inappropriately low ketones") Fatty acid oxidation defect (e.g., MCAD deficiency)
- Normal at birth, musty odor, developmental delay after missed/delayed screening Phenylketonuria
- Jaundice, vomiting, E. coli sepsis after milk feeds; reducing substances in urine Classic galactosemia
- Maple-syrup odor, poor feeding, encephalopathy in first week Maple syrup urine disease
- Immediate Management Principles (Exam-Level)
When an IEM is suspected in a decompensating infant: stop protein intake (remove the metabolic substrate), provide intravenous glucose to halt catabolism (catabolic states worsen ammonia and organic acid production by breaking down endogenous protein), send critical labs (ammonia, blood gas, glucose, lactate, urine and plasma amino/organic acids) before results delay treatment, and involve a metabolic specialist urgently — ammonia in particular is directly neurotoxic, and the duration of hyperammonemic coma correlates with neurologic outcome, so rapid recognition and treatment are what the exam is really testing.